Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer - PubMed (original) (raw)
. 2004 Jan 1;108(1):152-7.
doi: 10.1002/ijc.11404.
Affiliations
- PMID: 14618630
- DOI: 10.1002/ijc.11404
Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer
Jocelyn Céraline et al. Int J Cancer. 2004.
Abstract
Androgen receptor (AR) mutations that modify both the ligand binding and the transactivation capacities of the AR represent one of the mechanisms involved in the transition of prostate cancer (PCa) from androgen-dependent to androgen-independent growth. We use a yeast-based functional assay to detect and analyze mutant ARs in PCa. We report the detection of 2 different mutant ARs within the same metastatic tumour sample harvested in a patient with advanced PCa who had escaped androgen deprivation. Concomitantly to the widely described T877A mutant AR, we identified an additional double mutant AR harboring the nonsense mutation Q640Stop just downstream the DNA binding domain together with the T877A point mutation. This type of mutation, which leads to a c-terminal truncated AR, has not been described yet in PCa. Using luciferase reporter assays we demonstrated that this truncated AR exhibited constitutive transactivation properties. In conclusion, our data suggest that mutation-induced constitutive activation of the AR could be a mechanism used by PCa cells to escape androgen deprivation.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
- Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, Balk SP. Taplin ME, et al. Cancer Res. 1999 Jun 1;59(11):2511-5. Cancer Res. 1999. PMID: 10363963 - Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Marcias G, Erdmann E, Lapouge G, Siebert C, Barthélémy P, Duclos B, Bergerat JP, Céraline J, Kurtz JE. Marcias G, et al. Hum Mutat. 2010 Jan;31(1):74-80. doi: 10.1002/humu.21138. Hum Mutat. 2010. PMID: 19830810 - The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
Haelens A, Tanner T, Denayer S, Callewaert L, Claessens F. Haelens A, et al. Cancer Res. 2007 May 1;67(9):4514-23. doi: 10.1158/0008-5472.CAN-06-1701. Cancer Res. 2007. PMID: 17483368 - Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C. Sampson ER, et al. J Biol Regul Homeost Agents. 2001 Apr-Jun;15(2):123-9. J Biol Regul Homeost Agents. 2001. PMID: 11501969 Review. - Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA, Yen AE, Weigel NL. Shafi AA, et al. Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13. Pharmacol Ther. 2013. PMID: 23859952 Review.
Cited by
- JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells.
Laschak M, Spindler KD, Schrader AJ, Hessenauer A, Streicher W, Schrader M, Cronauer MV. Laschak M, et al. BMC Cancer. 2012 Mar 30;12:130. doi: 10.1186/1471-2407-12-130. BMC Cancer. 2012. PMID: 22462810 Free PMC article. - Androgen receptor repression of GnRH gene transcription.
Brayman MJ, Pepa PA, Berdy SE, Mellon PL. Brayman MJ, et al. Mol Endocrinol. 2012 Jan;26(1):2-13. doi: 10.1210/me.2011-1015. Epub 2011 Nov 10. Mol Endocrinol. 2012. PMID: 22074952 Free PMC article. - A Standardized Wedelia chinensis Extract Overcomes the Feedback Activation of HER2/3 Signaling upon Androgen-Ablation in Prostate Cancer.
Tsai CH, Tzeng SF, Hsieh SC, Tsai CJ, Yang YC, Tsai MH, Hsiao PW. Tsai CH, et al. Front Pharmacol. 2017 Oct 10;8:721. doi: 10.3389/fphar.2017.00721. eCollection 2017. Front Pharmacol. 2017. PMID: 29066975 Free PMC article. - The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.
Fiandalo MV, Wu W, Mohler JL. Fiandalo MV, et al. Curr Drug Targets. 2013 Apr;14(4):420-40. doi: 10.2174/1389450111314040004. Curr Drug Targets. 2013. PMID: 23565755 Free PMC article. Review. - Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.
Uo T, Dvinge H, Sprenger CC, Bradley RK, Nelson PS, Plymate SR. Uo T, et al. Oncogene. 2017 Mar;36(10):1440-1450. doi: 10.1038/onc.2016.313. Epub 2016 Oct 3. Oncogene. 2017. PMID: 27694897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials